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Abstract
Background: The United States is in the midst of an opioid epidemic. Long-term use of opioid medications is associated with
an increased risk of dependence. The US Centers for Disease Control and Prevention makes specific recommendations regarding
opioid prescribing, including that prescription quantities should not exceed the intended duration of treatment.
Objective: The purpose of this study was to determine if opioid prescription quantities written at our institution exceed intended
duration of treatment and whether enhancements to our electronic health record system improved any discrepancies.
Methods: We examined the opioid prescriptions written at our institution for a 22-month period. We examined the duration of
treatment documented in the prescription itself and calculated a duration based on the quantity of tablets and doses per day. We
determined whether requiring documentation of the prescription duration affected these outcomes.
Results: We reviewed 72,314 opioid prescriptions, of which 16.96% had a calculated duration that was greater than what was
documented in the prescription. Making the duration a required field significantly reduced this discrepancy (17.95% vs 16.21%,
P<.001) but did not eliminate it.
Conclusions: Health information technology vendors should develop tools that, by default, accurately represent prescription
durations and/or modify doses and quantities dispensed based on provider-entered durations. This would potentially reduce
unintended prolonged opioid use and reduce the potential for long-term dependence.
(JMIR Med Inform 2020;8(3):e16199)  doi: 10.2196/16199
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Introduction
The United States is in the midst of an opioid epidemic [1,2].
The rate of death from opioids is increasing; more than 67% of
the 70,237 overdose deaths in the United States in 2017 were
attributed to opioid drugs [3]. Drug overdoses could soon
become the number one cause of death of Americans under the
age of 50 years [4]. Opioid overdoses are a public health crisis
associated with significant medical costs and resource utilization
[5-11]. Chronic opioid use is often preceded by treatment of
acute pain [12], and long-term prescription opioids are
associated with progression to illicit opioid abuse [13]. Despite
the clear correlation between prescription opioid use and
mortality, opioids continue to be routinely prescribed [2,14,15].
While the United States makes up only 4.3% of the global
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population [16], Americans consume more than 80% of the
world’s supply of opioid medications [17].
In the Commonwealth of Pennsylvania, there were 5456
drug-related overdoses in 2017 [18], the third-highest of any
state for drug-related deaths in the nation [19]. In 2016, 60%
of all Pennsylvania counties had prescribing rates higher than
the national average. In 2017, even though there was an overall
decline in opioid prescriptions, enough oxycodone and
hydrocodone were dispensed to provide every Pennsylvanian
with 32 dosage units of these drugs [18].
Reduction in the number of opioid prescriptions, opioid doses,
and duration of treatment are critical to curbing the opioid
epidemic. State prescription drug monitoring programs (PDMPs)
allow physicians to assess a patient’s controlled-substance
prescription history [20]. Chronic opioid use and risk of death
have been associated with higher prescription doses and longer
durations [12,21]. After the third day of use in an opioid-naïve
individual, the likelihood of chronic opioid use increases daily.
This increase is most drastic on days 5 and 31 [22]. Therefore,
the US Centers for Disease Control and Prevention (CDC) has
authored guidelines on opioid dosing and duration for acute and
chronic pain [23,24]. Specifically, they recommend a duration
of 3 days or less for acute pain, and advise that more than 7
days is unlikely to be required. The CDC also recommends that
prescriptions should be of no greater quantity than what is
required for the duration of treatment [23]. Consequently, opioid
prescriptions with unintentionally prolonged durations of
treatment may result in increased risk of chronic opioid use and
associated morbidity and mortality [25].
Health information technology can play a critical role in
improving quality of care while improving guideline adherence
and decreasing errors [26]. Electronic health records (EHRs)
have been associated with advanced quality of patient care
[27-29], and computerized provider order entry (CPOE) is
associated with improved efficiency and safety [30]. CPOE can
improve medication ordering through clinical decision support
systems in both active (ie, a pop-up warning of drug-drug
interactions) and passive (ie, a dose-appropriate default
prescription setting) approaches [31].
Some health information technology interventions that require
providers to review aspects of current or prior opioid
prescriptions have been demonstrated to affect opioid
prescribing patterns. For instance, PDMP mandates that require
the review of controlled substance prescription history prior to
and during opioid prescribing have demonstrated a reduction
in opioid prescribing rates [32]. Additionally, while some
hospitals have attempted to control opioid prescribing patterns
through prescription presets of a specific number of tablets
[33,34], others have demonstrated both reductions and increases
in tablets dispensed when requiring manual entry of number of
tablets to dispense in a prescription [35,36].
Our current vendor-based EHR’s CPOE ordering screen has
four fields for opioid prescription entry: (1) dose (ie, number
of tablets), (2) frequency (eg, three times a day), (3) duration
(ie, number of doses or days), and (4) quantity (ie, the number
of tablets dispensed). Previously, the system did not
auto-calculate duration from dose, frequency, and quantity or
vice versa. Instead, it alerted the provider within the CPOE
ordering screen and recommended updating the duration or
quantity. This means a provider could write a prescription with
a duration of 3 days and a quantity of 200 tablets with only a
soft alert. Additionally, prior to August 2018, our institution
did not require a duration value to be entered into our CPOE,
meaning this field could be left blank. In August 2018, we
introduced a number of interventions via modifications to our
EHR’s opioid prescription settings: (1) duration was set to be
a required field, (2) a quick button for 3 days’ duration was
added to coincide with CDC guidelines for acute pain, and (3)
tablet quantity for all opioid orders was preset to 10.
The purpose of this research is to examine if there are
differences between the duration of treatment as written in an
opioid prescription versus the duration associated with the
dosing frequency and number of pills dispensed. That is to say,
we examined how long the number of dispensed pills at the
prescribed frequency would last (ie, the calculated duration)
and compared that to the duration documented by the prescriber
(ie, the written duration) for opioids ordered by providers at
our institution. Additionally, we examined whether the
requirement of a value in the duration field—from the
interventions described above—had any effect on accurately
representing the calculated duration of the prescription. We
take special interest in those durations that are calculated to be
longer than what was written in the duration field, as these
directly contradict the CDC prescribing guidelines [23] and
may increase risk of the associated negative effects of prolonged
opioid use.
Methods
Data Acquisition
We queried the EHR system of the Center City division of our
health care system, which includes an urban academic tertiary
care center, an urban academic community hospital, and multiple
ambulatory clinics. We examined data generated by Epic (Epic
Systems Corporation) via a third-party analytics software, Qlik
Sense (QlikTech International), to develop a list of all outpatient
opioid prescriptions, including discharge medications, written
over 22 months from October 2017 to July 2019. This includes
an 11-month preintervention period and an 11-month
postintervention period.
We extracted a number of variables, including the quantity of
tablets, the dosage units (ie, mg), the route of administration
(ie, oral vs buccal), the discrete dose (ie, 15 mg vs 10-15 mg,
based on the number of tablets per dose), the written duration,
and the frequency of administration.
For the purposes of this study, we limited the route of
administration to oral and excluded all nontablet formulations.
Finally, we excluded the medications buprenorphine and
methadone, as these are routinely used for the management of
opioid use disorder.
Calculated Duration
In order to compute the calculated duration of each prescription,
we took each of the unique possible frequencies in the system
(ie, twice a day or every 4 hours) and mapped these to the
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equivalent number of administrations per 24-hour day. For pro
re nata (PRN) medications, we selected the maximum frequency
possible. Therefore, “twice a day PRN” resulted in two daily
administrations and “every other day” resulted in a daily
administration of 0.5.
Next, we took all doses that contained ranges for their discrete
dose (ie, 20-30 mg) and isolated the maximum dose possible
per administration (ie, 30 mg). We calculated the number of
tablets per administration by dividing the maximum dose by
the dose per tablet. We calculated the total number of possible
doses by dividing the quantity dispensed by number of tablets
per administration. Finally, we computed the calculated duration,
measured in days, by dividing the total number of doses by the
number of administrations per 24 hours. The choice of the
maximum dose per administration means that our calculated
duration is the shortest possible when holding the other variables
constant.
Statistical Analysis
We first converted all written durations to be represented in
units of days. We then examined the proportion of prescriptions
that did not have a written duration to determine if our
intervention had an effect on the documentation of this field.
We also examined the proportion of prescriptions for which we
could not compute a calculated duration to ensure the
preintervention and postintervention periods were similar.
Finally, we compared the number of prescriptions written with
ranges (ie, 20-30 mg) to see if our intervention had an effect on
this category of prescriptions.
To compare what was documented (ie, written duration) to what
was dispensed (ie, calculated duration) for each prescription,
we then generated our study cohort by excluding any
prescription that did not hold a value for both of these fields.
Also, since we computed the calculated duration in units of
days, we excluded all written durations not also documented in
units of days.
We examined the written duration of each prescription and
compared it to the calculated duration. We categorized each
relationship as a written duration equal to, greater than, or less
than the calculated duration. We examined whether there were
any changes in the relationships between written duration and
calculated duration before and after our interventions, with
specific interest regarding the requirement to document a written
duration. See Table 1 for examples of each field and how we
coded relationships.
Table 1. Examples of each field extracted from the electronic health record system, with written duration and calculated duration demonstrated, along
with their relationship.
RelationshipCalculated
durationa
Maximum dose per
administration
Administrations
per day
Written
duration
Dispense
quantity
Prescription instructionsDrug
Written duration is
equal to calculated
duration
3 days30 mg (2 tablets)23 days12Take 1-2 tablets as needed
twice a day for 3 days
Morphine:
15 mg
tablets
Written duration is
longer than calculat-
ed duration
2 days30 mg (2 tablets)23 days8Take 1-2 tablets as needed
twice a day for 3 days
Morphine:
15 mg
tablets
Written duration is
shorter than calculat-
ed duration
5 days30 mg (2 tablets)23 days20Take 1-2 tablets as needed
twice a day for 3 days
Morphine:
15 mg
tablets
aCalculated duration=((quantity of tablets × drug dose in mg) / maximum dose per administration) / administrations per day.
Data cleaning and calculations were performed in Qlik Sense.
Statistical analysis was performed in the statistical software R,
version 3.3.2 (The R Foundation). Chi-square analysis was used
for categorical values. The t test was used for parametric data
and the Wilcoxon rank-sum test was used for nonparametric
data.
Results
General Results
There were 92,462 unique opioid prescriptions that met initial
inclusion criteria during our study period for 30,426 individual
patients. There was a mean number of prescriptions per month
of 4202.82 (SD 204.32) and a median number of prescriptions
per person per month of 1 (IQR 1-2).
In the preintervention period, there were 47,131 prescriptions
for 16,863 individual patients; in the postintervention period,
there were 45,331 prescriptions for 17,483 individual patients.
There was no significant difference (P=.06) between mean
number of prescriptions per month in the preintervention period
(mean 4284.64 [SD 200.68]) versus the postintervention period
(mean 4121.00 [SD 180.74]). The median number of 1
prescription per person per month did not change (IQR 1-2,
P=.37).
There was a statistically significant decrease in the proportion
of prescriptions with no written duration documented
postintervention (33.54%, 95% CI 33.12-33.97, vs 9.45%, 95%
CI 9.19-9.72, P<.001). Evaluation of the remaining 9.45% of
prescriptions without a written duration appear to be due to
refills of prior prescriptions, which were exempt from the new
documentation requirement.
There was a small but significant difference in the proportion
of prescriptions in which we were unable to compute the
calculated duration when comparing the preperiod and the
postperiod (6.01%, 95% CI 5.80-6.23, vs 3.61%, 95% CI
3.44-3.79, P<.001).
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There was no significant difference pre- and postintervention
in the number of prescriptions that contained ranged doses (ie,
20-30 mg) (4.42%, 95% CI 4.23-4.61, vs 4.66%, 95% CI
4.47-4.86, P=.08).
There were 72,364 out of 92,462 (78.26%) total prescriptions
that had a written duration documented. Of these, there were
2632 (3.64%) prescriptions whose written duration units were
converted from other duration units to days, while the rest were
already written in this unit of measurement. Out of 72,364
prescriptions, 50 (0.07%) were excluded because the calculated
duration could not be computed. This resulted in 72,314 out of
92,462 (78.21%) total prescriptions meeting the inclusion criteria
for our comparison: out of 72,314 prescriptions, 31,300
(43.28%) were in the preintervention period and 41,014
(56.72%) were in the postintervention period. Figure 1
demonstrates the inclusion and exclusion criteria and separate
cohorts for comparison.
Figure 1. Breakdown of cohorts based on inclusion and exclusion criteria and separation into preperiod and postperiod cohorts.
Comparison of Written and Calculated Durations
Of the 72,314 prescriptions, 41.97% (30,353 total, 95% CI
41.61-42.33) had calculated durations that were equivalent to
their written durations, 41.06% (29,694 total, 95% CI
40.70-41.42) had calculated durations that were less than their
written durations, and 16.96% (12,267 total, 95% CI
16.69-17.24) had a calculated duration that was greater than the
written duration.
Requiring a written duration to be documented significantly
improved the number of calculated durations that were equal
to their corresponding written duration, from 38.86%
(12,163/31,300, 38.86%, 95% CI 38.32-39.40) to 44.35%
(18,190/41,014, 44.35%, 95% CI 43.87-44.83, P<.001).
Additionally, requiring a written duration resulted in a reduction
in prescriptions where the calculated duration was longer than
the written duration (5617/31,300, 17.95%, 95% CI 17.52-18.37,
vs 6650/41,014, 16.21%, 95% CI 15.86-16.57, P<.001). Changes
in percentages of each relationship between written duration
and calculated duration, pre- and postintervention, are presented
in Table 2.
Table 2. Totals and percentages of each cohort and their associated relationships for pre- and postintervention.
Total (N=72,314), n (%)P val-
ue
Postperiod (N=41,014), n (%)Preperiod (N=31,300), n (%)Relationship
30,353 (41.97)<.00118,190 (44.35)12,163 (38.86)Calculated duration equal to written duration
29,694 (41.06)<.00116,174 (39.44)13,520 (43.19)Calculated duration less than written duration
12,267 (16.96)<.0016650 (16.21)5617 (17.95)Calculated duration greater than written duration
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Discussion
Principal Findings
The opioid epidemic is a major concern in the United States,
specifically in the Commonwealth of Pennsylvania [1,18] where
the governor has issued a state emergency disaster declaration
since 2018 [37]. Our hospitals and clinics are located in the
heart of a major urban area within the state, in a county that
hosts the highest estimated frequency of overdose deaths [38]
and neighbors a district considered to be the epicenter for illicit
opioid trade in the region [39].
In order to aid in many state-, city-, and hospital-level initiatives,
our clinical informatics group has recently employed solutions
to combat the opioid epidemic. These include simplifying PDMP
queries, modifications of prescription settings in the emergency
department, and analytics tools to track opioid prescribing
throughout the institution [40,41].
Reduction in opioid prescriptions is a key step in combating
this epidemic, and the duration of prescriptions has a significant
effect on a patient’s risk of becoming a chronic opioid user
[12,22].
In order to study our upcoming planned interventions, we
realized we needed a reliable way to calculate durations of
opioid prescriptions. Given the prior lack of requirement to
document a written duration in our EHR system, we wanted to
explore whether this was an accurate representation of a
prescription’s true duration and whether making this a
requirement improved overall representation of the duration of
a prescription as measured by the calculated duration.
Overall, written duration was equal to the calculated duration
(41.97%) or less than the calculated duration (41.06%) the
majority of the time. However, 16.96% of the time our
prescriptions had a longer calculated duration than the written
duration, which contradicts CDC prescribing guidelines. We
are concerned that unintentionally prolonged opioid prescription
durations could be contributing to an increased risk of opioid
dependence. We must take this opportunity to stress that we do
not imply that these prescriptions were intentionally written to
break guidelines or to prolong a patient’s duration of opioid
therapy. We are simply stating that we observed a difference in
these two values and we believe this requires attention. One
solution to this issue could be modifications to the EHR system.
In order to provide peak levels of patient safety and end-user
satisfaction, EHRs require continuous review and optimization.
A lack of a required field allowed prescription durations to not
match what the provider had documented, or likely intended.
This is apparent in that requiring documentation of this field
reduced those prescriptions without written durations, improved
the percentage of written durations that accurately represented
their corresponding calculated durations, and reduced the
number of calculated durations that exceeded written durations.
As discussed in our results, we explored the remaining 9.45%
of prescriptions that continued to lack a written duration after
our intervention and determined that they were likely due to
renewals of prescriptions written prior to our modifications,
where the system allows the field previously left blank to
remain. Additionally, our intervention did yield a small but
significant reduction in prescriptions where we were unable to
compute a calculated duration (6.01% vs 3.61%). We attribute
this to the addition of a quick button, as described in our
methods.
Many studies have demonstrated how modifications to CPOE
can affect opioid prescribing, though most of the literature
focuses on tablet counts and not duration of treatment. Delgado
et al demonstrated that when transitioning from an EHR that
had no preset dispense quantity to an EHR that required a preset
of 10 tablets, the median number of oxycodone 5 mg/
acetaminophen 325 mg tablets dispensed by two emergency
departments decreased from 11.3 to 10.0 and from 12.6 to 10.9,
respectively [33]. Similarly, Chiu et al demonstrated that when
opioids were prescribed at discharge for outpatient surgery,
modification of the default pill count from 30 tablets to 12
tablets reduced the median number of tablets dispensed from
30 to 20 tablets [34]. However, they did not examine
prescription duration, noting that duration guidelines are usually
“far longer than most patients will need,” and modifications of
number of tablets dispensed will have a more profound affect
[34]. While we believe reduction of tablets dispensed is critical
to combating the opioid epidemic, at this time, CDC guidelines
consider prescription duration to be an important measurement
in reducing opioid therapy and combating the epidemic [23,24].
Conversely, other studies have demonstrated results from
entirely removing presets for opioid tablets dispensed.
Santistevan et al showed that in an emergency department
setting, removal of the default of 20 tablets for hydrocodone
and oxycodone, and the requirement of the prescriber to enter
a number of tablets to dispense, reduced the median number of
tablets prescribed from 20 to 15 [35]. The authors concluded
that EHR presets may hinder providers’ ability to prescribe
opioids to appropriately fit the variability in patient care (ie,
more painful clinical conditions need more tablets) and that
prescriptions written at the provider’s discretion may be more
appropriate. Contrary to these results, Zwank et al demonstrated
an increase in mean number of tablets from 15.31 to 15.77 after
removing their 15-tablet preset and requiring manual entry of
tablets dispensed [36].
Crothers et al also examined the effects of transitioning between
EHR systems, from a homegrown system to a vendor-based
system [42]. Their prior EHR system auto-calculated the
maximum number of dispense units for PRN opioid
prescriptions based on dose, frequency, and duration
documented. During their implementation, they removed this
functionality and instead developed preset dispense quantities,
with outpatient prescriptions for clinics and inpatient discharges
defaulted to 30 tablets for oxycodone and null for hydrocodone.
This resulted in a decrease of 1.4 dispense units overall and 3.9
dispense units for inpatient discharge [42].
While these studies have examined the effect of changes in the
requirement to document the number of tablets dispensed
[33-36], to our knowledge we are the first to examine the
requirement of documenting a duration field and comparing the
duration intended by a prescriber (ie, written duration) to the
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calculated duration based on the number of tablets dispensed
and instructions provided.
Our results confirm that simple documentation of an opioid
prescription’s duration is not sufficient. When a duration field
is not directly linked to other elements of the prescription and
there is no automated calculation of duration from dose,
frequency, and quantity—or vice versa—inaccuracies remain.
While it is interesting that Crothers et al demonstrated that
removal of such functionality reduced opioid dispensing [42],
this was performed during a transition of EHR systems and with
the addition of prescription presets, which likely influenced
their results. Given the importance of the duration of an opioid
prescription in the associated risk of long-term use, as well as
further potential for overdose, it is vital to have data that
accurately represents this value. Additionally, we have
demonstrated that retrospective computation of a calculated
duration is a viable alternative when written durations are not
available for the study of EHR prescribing data.
In order to improve compliance to CDC opioid prescribing
guidelines, EHR system vendors should consider rapidly
developing tools that, by default, accurately represent
prescription durations and/or modify doses and quantities
dispensed based on provider-entered durations. As described
in the Introduction, this calculation already exists in our system,
but no hard stop or passive updating of prescription fields exists.
If a provider intends to prescribe one tablet, three times a day
for 3 days, the system should automatically set the quantity at
nine tablets; if the provider reduces the quantity to six tablets,
the duration of the prescription should automatically be reduced
to 2 days.
Limitations
Our study was performed at a single, urban academic institution
and its associated ambulatory clinics; therefore, our results may
not represent the majority of the country’s hospitals. However,
given that our institution is located in the state with the
third-highest rate of drug overdose, our results may be valid
when compared to other states of similar rates of overdose.
Additionally, as discussed in our methods, we intentionally
biased our process of computing the calculated duration to make
our resulting durations as short as possible by assuming
individual doses were the higher of the possible range (ie, if a
possible dose was 5-10 mg, we assumed the dose was 10 mg,
thereby meaning that the quantity was used faster and the
duration was shorter). This means that our calculations may
underrepresent the number of prescriptions where the calculated
duration was longer than the written duration if patients were
to ration their medications and take lower doses over a longer
period of time. Further, while our main intervention was making
the duration field a requirement, we also added quick-action
buttons and modified some prescription settings, which may
have influenced our postperiod results, though we expect this
to have been minimal. Finally, we used EHR data to represent
durations of medications. While we believe it is important for
our prescriptions to accurately represent the intended therapy
and to abide by CDC guidelines, we did not determine whether
individual patients took their prescribed medication as written,
nor did we examine whether each prescription was filled at a
pharmacy.
Conclusions
Accurate documentation of an opioid prescription’s duration is
critical, both for patient safety and for secondary use in analysis
of the status of the opioid epidemic, as well as for evaluating
interventions implemented to combat this public health crisis.
Our study demonstrates that more than 17% of prescriptions
written at our institution had durations documented in the EHRs
that were shorter than durations calculated via the dose,
frequency, and quantity of tablets prescribed. Requiring
documentation of the duration field in a prescription improved
these errors statistically but, clinically, a large number of
prescriptions continued to not match the calculated duration.
EHR vendors should invest in research and development to
create functions that automatically calculate and fill values of
the opioid prescription to ensure prescriptions are accurately
represented, while physicians and hospitals should invest in
informatics initiatives to study and improve provider-prescribing
practices.
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